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Summary 
The data presented in this paper describe trends in drug-related deaths in Ireland 
between 1998 and 2005. The data used for this analysis were obtained from the 
National Drug-Related Deaths Index (NDRDI) which is maintained by the Alcohol and 
Drug Research Unit of the Health Research Board. Using four different data sources, 
the NDRDI has identified deaths which were either directly or indirectly attributable to 
drug use. This data gives a reliable estimate of the total burden of mortality related to 
drug use in Ireland. This publication presents the first analysis of such data from the 
NDRDI. 
The main results of the analysis may be summarised as follows: 
• 	 A total of 2,442 drug-related deaths recorded between 1998 and 2005 were 
entered on the NDRDI database. Of these, 1,553 were directly drug-related 
deaths (poisonings) and 889 were indirectly drug-related deaths (non­
poisonings). 
• 	 The annual number of deaths by poisoning increased from 178 in 1998 to 232 
in 2005. 
• 	 The majority of deaths by poisoning were males. 
• 	 The majority of deaths by poisoning were in people aged 20 to 40 years. 
• 	 Of the 1,553 cases of death by poisoning, 714 (46.0%) were attributable 
to a single drug or substance. Heroin and unspecified opiates accounted for 
159 (22.3%) of the single-drug poisonings, analgesics containing an opiate 
compound accounted for 85 (11.9%) deaths, and methadone accounted for a 
further 61 (8.5%) deaths. 
• 	 Just over half of all poisonings (839, 54%) were due to polysubstances and the 
annual proportion was similar in each year of the eight-year period. 
• 	 Of the polysubstance deaths, 388 (46.2%) involved polysubstances which 
included an opiate (mainly heroin or methadone). A further 177 (21.1%) 
involved polysubstances which included an analgesic containing an opiate 
compound. 
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• 	 The number of deaths by poisoning in which cocaine was implicated rose from five in 1998 to 34 in 
2005. In total, cocaine was implicated in 100 cases (6.4% of all deaths by poisoning). Of the deaths 
where cocaine was involved, 29% were due to cocaine alone. 
• 	 Prescription medication and over-the-counter medication was implicated in many of the deaths 
by poisoning. Benzodiazepines played a major role in polysubstance poisonings. In total, 
benzodiazepines were involved in 30% of deaths by poisoning. 
• 	 One-quarter (380, 24.5%) of all deaths by poisoning involved alcohol in conjunction with another 
drug or substance. This is an underestimation of the total number of such deaths as cases of 
poisoning by alcohol alone are not included in this analysis. 
• 	 In the eight-year period, there were 33 deaths in which the use of solvents was implicated. These 
deaths occurred mainly in young people aged under 19 years. 
• 	 In the years 2003 to 2005, the number of deaths by poisoning that occurred outside Dublin 
surpassed the number of deaths by poisoning in Dublin (city and county). 
• 	 The number of deaths indirectly related to drug use and/or substance use increased over the period, 
from 64 in 1998 to 168 in 2005. This reflects the increasing numbers of people in the population 
who are consuming drugs, taking risks, developing dependencies, or who have developed other 
illnesses associated with drug use. 
Glossary 
Drugs of dependence or abuse: Opiates (including heroin, methadone, morphine, codeine), stimulants
(including cocaine, ecstasy), cannabis, hallucinogens (including LSD), alone or in combination. Cases involving
dependence or abuse of licit drugs such as benzodiazepines, steroids and licit opiates either alone or in
combination with any other drug are included where information on dependence or abuse was available. 
Drug users: Individuals who have a history of drug dependency or of non-dependent abuse of drugs and/ 
or other substances. 
Median: The median is the value at the mid-point in a sequence of numerical values ranged in ascending 
or descending order. It is defined as the value above or below which half of the values lie. Unlike the 
mean (average), the median is not influenced by extreme values (or outliers). For example, in the case of 
five drug users aged 22, 23, 24 and 46 years respectively, the median (middle value) is 24 years, whereas 
the mean is 27.8 years. While both the median and the mean describe the central value of the data, the 
median is more useful in this case because the mean is influenced by the one older person in this example. 
Non-poisonings: Deaths in individuals with a history of drug dependency or non-dependent abuse of 
drugs (ascertained from toxicology results, Central Treatment List, medical or coronial records) whether or 
not the use of the drug was directly implicated in the death. 
Other substances include solvents, fungi, fruit, insecticides and herbicides. 
Poisonings: Deaths in individuals directly due to the toxic affect of the consumption of a drug(s) and/or 
other substance(s). Deaths arising from adverse reactions to prescribed medication are not included in the 
NDRDI. 
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Polysubstance cases are those that had two or more drugs or substances implicated in their cause of death. 
Solvents: Breathable chemical vapours that are intentionally inhaled because of the chemicals’ mind-
altering effects. Solvents include glue, fuel, aerosols or gas. 
Unspecified Opiates: Post-mortem toxicology cannot always distinguish the actual opiate substance and 
therefore some drugs have to be classified as an unspecified opiate-type drug. 
Acronyms 
ADRU Alcohol and Drug Research Unit 
AIDS Acquired Immune Deficiency Syndrome 
CTL Central Treatment List 
CSO Central Statistics Office 
DTF Drugs Task Force 
EMCDDA European Monitoring Centre for Drugs and Drug Addiction 
ESRI Economic and Social Research Institute 
FSN Family Support Network 
HIPE Hospital In-Patient Enquiry scheme 
HIV Human Immunodeficiency Virus 
HRB Health Research Board 
ICD International Classification of Diseases 
LDTF Local Drugs Task Force 
LSD Lysergic acid diethylamide 
NDRDI National Drug-Related Deaths Index 
RTFA Regional Task Force Area 
WHO World Health Organization 
In the case of data presented by region, this paper refers to the areas covered by the regional drugs task 
forces (RDTFs), together with the local drugs task forces (LDTFs) within their boundaries, as follows: 
Area included 
ECRDTF East Coast Regional Drugs Task Force (DTF) South-east Dublin city and county and East Wicklow, including the 
two local drugs task force (LDTF) areas within these boundaries 
MRDTF Midland Regional DTF Counties Laois, Longford, Offaly and Westmeath 
MWRDTF Mid West Regional DTF Counties Clare and Limerick, and North Tipperary 
NDRDTF North Dublin City and County Regional DTF North Dublin city and county, including the five LDTF areas
within these boundaries 
NERDTF North Eastern Regional DTF Counties Cavan, Louth, Meath and Monaghan 
NWRDTF North West Regional DTF Counties Donegal, Leitrim and Sligo, and north-west Cavan 
SERDTF South East Regional DTF Counties Carlow, Kilkenny, Waterford and Wexford, and South
Tipperary, 
SRDTF Southern Regional DTF Counties Cork and Kerry, including the Cork LDTF area 
SWRDTF South Western Regional DTF South-west Dublin, West Wicklow and County Kildare,
including the six LDTF areas within these boundaries 
WRDTF Western Regional DTF Counties Galway, Mayo and Roscommon 
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Introduction 
The National Drug-Related Deaths Index (NDRDI) is an epidemiological database which records cases of 
death by drugs and alcohol poisoning, and deaths among drug users and among alcoholics in Ireland. The 
NDRDI is maintained by the Alcohol and Drug Research Unit (ADRU) of the Health Research Board (HRB). 
It is jointly funded by the Department of Health and Children and the Department of Justice, Equality and 
Law Reform. 
The NDRDI was established in September 2005 to comply with Action 67 of the current National Drugs 
Strategy.1 The aim of this action was to put in place a system for recording drug-related deaths to enable 
the State to respond in a timely manner, with accurate data, on drug-related deaths and deaths among 
drug users. 
Measurement of drug-related deaths and deaths among drug users is one of the key indicators used to 
measure the consequences of problem drug use in Europe. The NDRDI enables accurate reporting of this 
key data to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). The EMCDDA has 
recommended that all EU member states establish a special register to record these deaths. 
Illicit drugs are involved in many cases of drug-related death; however, licit (prescribed) drugs are also 
frequently involved in such deaths (alone or in conjunction with an illicit drug).2,3 
Alcohol has been reported as the third most detrimental risk factor for ill health and premature death in 
Europe.4 The NDRDI has recorded data on alcohol-related deaths, deaths among alcoholics, and deaths 
from alcohol-related diseases for 2004 and 2005. An analysis of these data is not presented in this paper. 
Background 
Drug use can lead to premature death from a range of different causes.5 Many deaths are caused by 
poisoning (both intentional and unintentional), where the death is directly attributable to the consumption 
of drugs (alone or in combination with other substances). This type of death is often defined as a directly 
drug-related death. For the purpose of this paper, this type of death will be referred to as a poisoning. 
Deaths among drug users (whether dependent or non-dependent) are often indirectly attributed to the 
consequences of their drug use. This type of death is often defined as an indirectly drug-related death. For 
the purpose of this paper, this type of death will be referred to as a non-poisoning. There is wide variation 
in the causes of death in such cases: 
• 	 Infection with HIV due to sharing of drug paraphernalia and subsequent death due to an AIDS-
related illness is an example of an indirectly drug-related death. 
• 	 High rates of depression have been recorded among illicit drug users, and studies have shown that 
they are at greater risk of suicide than the population who do not use illicit drugs.5 Suicide deaths 
among illicit drug users that are not due to poisoning are recorded as indirectly drug-related deaths. 
However, the contribution of a history of drug use in this type of death is frequently not available, 
leading to an under-recording of the total number of indirectly drug-related deaths in the population. 
• 	 Actions taken while under the influence of drugs can lead to death, frequently as a result of accidents 
caused by impaired judgement or exacerbation of risky behaviours.5 
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• 	 In the case of some deaths, evidence of drug misuse may be an incidental finding on post-mortem. 
• 	 Finally, in some cases of indirectly drug-related death, the deceased was neither poisoned nor had 
misused drugs, but was the victim of violence (e.g. road traffic accident, drug crime, etc) as a 
result of the drug use of another individual. In line with international practice, these deaths are not 
recorded by the NDRDI. 
Calculation of mortality figures for both poisonings and non-poisonings provides an estimate of the total 
burden of mortality related to drug use in Ireland. 
Previous data 
The EMCDDA has developed a standardised method of extracting drug-related mortality data from various 
sources in all EU member states.6 This method involves the collection of information on drug-related 
deaths according to specific categories, using the International Classification of Diseases (ICD) to enable 
international comparisons.7 The ICD codes required varies depending on whether a country provides data 
from a General Mortality Register (GMR) or from a Special Register. Special Registers are usually maintained 
by the police or forensic services of a country and not all countries have a Special Register. The NDRDI can 
be considered a Special Register. 
To date, information on drug-related deaths in Ireland has been provided by the GMR, which is maintained 
by the Central Statistics Office (CSO). However, these data were felt to be an under-recording.8 A study 
in 2001 found that the annual numbers of opiate-related deaths recorded by the Dublin coroners were 
consistently higher than those reported by the GMR.9 Deaths as an indirect result of drug use have not 
been systematically documented and have only been assessed in a number of small-scale studies in Dublin 
city and county.8 Families of substance users in Dublin (through the Family Support Network [FSN]) 
have advocated for some years for the development of a mechanism to accurately measure the extent of 
premature death among drug users. 
Aim of the NDRDI 
The aim of the NDRDI is to ensure complete (90%) and accurate (95%) reporting of drug- and alcohol-
related deaths, and deaths among drug users and among alcoholics, in order to allow the State to respond 
in a timely manner with accurate data on such deaths. 
The objectives of the NDRDI are: 
• 	 To provide accurate information on drug- and alcohol-related deaths and deaths among drug users 
and among alcoholics; 
• 	 To assist in identifying and prioritising areas for intervention and prevention, and to measure the 
effects of such interventions. 
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Methods 
The data-collection tool was developed from those used in previous research and from tools developed by 
the EMCDDA.8 Data were collected retrospectively for each of the eight years between 1998 and 2005. 
Data collected includes: 
• demographic details 
• socio-economic information 
• history of drug and/or alcohol dependence or non-dependent abuse of drugs 
• risk factors e.g. history of injecting, imprisonment 
• drug and/or alcohol treatment history 
• details about the death itself: 
– toxicology 
– cause of death. 
Data sources 
In order to ensure a complete and accurate database, it is necessary to use data from several sources: the 
Coroner Service, the acute hospital sector through the Hospital In-Patient Enquiry scheme (HIPE), the 
Central Treatment List (CTL), the GMR and through the community via the FSN. 
The Coroner Service 
The primary objective of the Coroner Service in Ireland is to establish, following public investigation, the 
cause of death (including how the person died) in cases of sudden or unexpected death.10 In Ireland, a 
coroner has all the same absolute privileges as a judge. To establish the cause of death, the coroner can 
instigate further inquiries, such as ordering a post-mortem and, if necessary, an inquest. If the results of the 
post-mortem and any other tests establish the cause of death as being natural, the coroner can then issue a 
certificate to the Registrar of Births, Deaths and Marriages, enabling them to issue a death certificate. 
If the cause of death cannot be ascertained following a post-mortem, the coroner can order an inquest. An 
inquest must be held for all deaths that occur in a violent or unnatural manner, for all sudden deaths as 
well as those of an unknown cause. An inquest is concerned with establishing the facts of the death, rather 
than determining the innocence or guilt of any third party. Once the inquest has been completed, the final 
outcome is a matter of public record. 
NDRDI researchers collected data on site from the 48 current coroner districts countrywide, and entered
it into the database on laptops secured by encryption. The time between date of death and conclusion of
inquest varies from case to case.11 This means that information on some deaths which occurred between
1998 and 2005 could not be obtained from the coroners. The database will be updated as and when this
information becomes available. As a result, figures may change over time but numbers are likely to be small. 
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The Hospital In-Patient Enquiry scheme 
The Economic and Social Research Institute (ESRI) manages the HIPE scheme in Ireland. HIPE is a computer-
based health information system designed to collect medical and administrative data on discharges and 
deaths in acute general hospitals. Each HIPE discharge record represents one episode of care. Information 
is not recorded on cases that attend accident and emergency units for treatment but are not admitted 
as in-patients (these deaths come under the remit of the Coroner Service). This data source has never 
previously been used to examine drug-related deaths or deaths among drug users. 
Sixty acute general hospitals participate in the HIPE scheme. The estimated coverage of cases discharged 
from the hospitals participating in the scheme was approximately 95.5% between 1999 and 2004.12 The 
ICD codes used by HIPE changed over the reporting period (from ICD9 CM to ICD10 AM), which may have 
led to some small differences in classification. 
An automated programme was developed by the HIPE information technology department of the ESRI 
to extract the required information from the HIPE database on cases that died in hospital and had the 
appropriate NDRDI ICD codes. All hospitals attached to HIPE, with the exception of the Royal Victoria Eye 
and Ear Hospital, provided data which the NDRDI researchers downloaded on site. 
The Central Treatment List 
The CTL was established under Statutory Instrument No 225 following the Report of the Methadone 
Treatment Services Review Group 1998.13 This list is administered by the Drug Treatment Centre Board on 
behalf of the Health Service Executive and is a complete register of all patients receiving methadone (for 
treatment of opiate misuse) in Ireland. These data can provide information on deaths among people with a 
history of opiate dependence. The data on all deaths reported to CTL staff between 1 January 1998 and 31 
December 2005 were sent electronically in a secure format to the NDRDI. 
The General Mortality Register 
The Registrar of Births, Deaths and Marriages formally records all notified deaths in Ireland. Using this data, 
the CSO then categorises each death and the underlying cause of death using ICD codes, and returns 
this information to the GMR. If the gardaí investigate a death on behalf of the Coroner Service, they also 
provide supplementary information to the CSO related to the death (Form 104). For each death, only one 
underlying cause of death and only one external cause, which describes the circumstances under which the 
death occurred, are recorded. The main disadvantage of this method is that contributory factors, such as 
drug use, may not be recorded. Data are sent electronically from the CSO to the NDRDI. 
The Family Support Network 
The FSN was established in 2000 by the CityWide Drugs Crisis Campaign. It consists of national 
representatives of family support groups, individual family members and those working directly with the 
families of drug users. The FSN can submit information on drug-related deaths. This information is given 
voluntarily by family members to personnel from the Network, who then forward the information to the 
NDRDI. Informed consent is required prior to data collection. The FSN data collection is still in its pilot 
phase and did not contribute to this round of analysis. 
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Ethical approval 
Ethical approval for the NDRDI was obtained from the HRB ethics committee and from ethics committees 
covering each individual acute hospital providing HIPE data. Approval for the use of CTL data was obtained 
from the Methadone Prescribing Protocol Implementation Committee. All work was carried out in 
accordance with IEA/European Epidemiology Group guideline document.14 
Case matching 
Cases from the coroners’ files, HIPE, GMR and CTL were matched to avoid duplication and to enhance the 
amount of information available on each case. Cases could be matched on a selection of variables including 
name, gender, county of residence, date of birth and date of death. Cases from the coroners, CTL or HIPE 
did not need to have a match in order to be included in the database. Named data was not available from 
the GMR, so as to avoid duplication and over-estimation of the number of cases, GMR cases with no match 
were not included in this analysis. 
Types of cases included in the NDRDI 
Poisonings: Deaths in individuals directly due to the toxic effect of the consumption of a drug(s) and/ 
or other substance(s). Other terms used to describe death as a result of excessive consumption include 
overdose, directly drug-related death, drug-induced death and acute drug death. Deaths arising from 
adverse reactions to prescribed medication are not included in the NDRDI. 
Non-poisonings: Deaths in individuals with a history of drug dependency or non-dependent abuse of 
drugs (ascertained from toxicology results, CTL, medical or coronial records), irrespective of whether the 
use of the drug was directly implicated in the death, e.g. cardiac events after cocaine use. 
Analysis 
This is the first analysis of the NDRDI data. Between 1998 and 2005, 2,442 drug-related deaths and deaths 
among drug users met the criteria for inclusion in the NDRDI. The cases were obtained from four data 
sources, and 1,402 (57.4%) occurred in more than one source. 
Overall, the number of deaths increased between 1998 and 2005. In 2003, there was a notable decrease, 
but numbers increased again in 2004 and 2005. Of the 2,442 deaths, 1,553 (63.6%) were due to 
poisoning (Table 1). 
Table 1 Poisonings and non-poisonings by year of death, 1998 to 2005 (N = 2,442) 
2005 
All deaths 400 
Poisonings (n = 1553) 232 
Non-poisonings (n = 889) 168 
1998 1999 2000 2001 2002 2003 2004 
242 271 261 276 336 296 360 
178 187 182 175 210 184 205 
64 84 79 101 126 112 155 
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Directly drug-related deaths (poisonings) 
The number of deaths by poisoning increased from 178 in 1998 to 232 in 2005, although numbers 
fluctuated over the reporting period (Table 1). 
The majority of deaths were male (67.1%, 1,042) (Figure 1). 
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Figure 1 Poisonings by gender and by year, 1998 to 2005 (N = 1,553) 
Over half the cases (53.8%, 836) were aged between 20 and 40 years at the time of death (Figure 2). 
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Figure 2 Poisonings by age group, 1998 to 2005 (n = 1,553) 
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Overall, the median age at the time of death was 38 years. In general, males were younger than females 
(Table 2). 
Table 2 Poisoning, by median age and by gender, 1998 to 2005 (N =1,553) 
1998 1999 2000 2001 2002 2003 2004 2005 
Median age in years 
All deaths 38 36 38 37 37 38 39 38 
Range* 19–69 17–69 17–69 20–64 18–64 18–68 20–70 17–64 
Male 35 33 35 38 36 37 35 35 
Female 44 42 42 36 39 41 47 42 
* Age range presented is the 5TH to 95TH percentile (90% of cases are included within this range) 
Drugs involved in deaths by poisoning 
Of the 1,553 deaths by poisoning recorded between 1998 and 2005, 714 (46.0%) were attributable 
to a single drug. Over the eight-year period, the annual percentages of single-drug poisonings and 
polysubstance poisonings were similar (Table 3). 
Table 3 Single-drug and polysubstance deaths by poisoning, 1998 to 2005 (N = 1,553)
 1998 1999 2000 2001 2002 2003 2004 2005 
Single-drug poisoning
(n = 714) 
78
(43.8) 
91
(48.7) 
81
(44.5) 
87
(49.7) 
93
(44.3) 
84
(45.7) 
90
(43.9) 
110
(47.4) 
Polysubstance poisoning
(n = 839) 
100
(56.2) 
96
(51.3) 
101
(55.5) 
88
(50.3) 
117
(55.7) 
100
(54.3) 
115
(56.1) 
122
(52.6) 
Total 178 187 182 175 210 184 205 232 
Of the 714 cases of death due to a single drug, heroin and unspecified opiates accounted for 159 (22.3%), 
analgesics containing an opiate compound accounted for 85 (11.9%) and methadone alone accounted for 
a further 61 (8.5%). 
Fifty-four per cent of deaths by poisoning (839) were attributable to two or more drugs and/or substances. 
Of these, 388 (46.2%) were attributable to the use of an opiate (mainly heroin and/or methadone) 
in conjunction with at least one other drug or substance. A further 21% (177) were attributable to 
polysubstances which included an analgesic containing an opiate compound. 
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1998 1999 2000 2001 2002 2003 2004 2005 Total % 
All deaths* 178 187 182 175 210 184 205 232 1553 100 
Heroin 29 48 37 47 46 28 29 44 308 19.8 
Methadone 43 37 40 27 39 33 40 42 301 19.4 
Other opiates† 39 35 45 54 46 48 64 60 391 23.3 
Cocaine 5 5 5 8 14 10 19 34 100 6.4 
MDMA 4 8 8 6 10 11 12 10 69 4.4 
Benzodiazepines 78 72 73 55 70 60 76 71 555 29.9 
Alcohol‡ 35 43 38 38 56 48 63 59 380 24.5 
Antidepressants 32 34 41 39 47 44 51 49 337 19.3 
Other prescription drugs§ 38 36 35 19 33 37 41 34 273 15.8 
Non-opiate analgesics 12 17 11 16 16 11 12 20 115 7.1 
Insecticides and herbicides 6 6 3 7 5  8  2  5  42  2.7  
Solvents 3 5 3 3 6  3  2  8  33  2.1  
Other ** 5 6 7 2 10  3  5  6  44  2.8  
Table 4 presents all drugs and other substances implicated in cases of death by poisoning (both single and 
polysubstance). Heroin was recorded as one of the drugs implicated in 20% of cases, while other opiates 
(including analgesics containing an opiate compound) were implicated in 23% of cases. Benzodiazepines 
were implicated in 30% of deaths. Poisoning by benzodiazepines occurred almost always in conjunction 
with another drug or substance. Alcohol in conjunction with another drug was implicated in one-quarter of 
deaths (24.5%). 
The number of poisoning deaths where cocaine was implicated, alone or with another drug, increased 
steadily from five in 1998 to 34 in 2005. In the eight-year period, cocaine was involved in 100 (6.4%) 
deaths by poisoning. Of these, 29 (29.0%) were due to cocaine alone. Heroin and/or methadone were 
often associated with cocaine in cases of polysubstance poisoning. 
Table 4 Drugs involved in deaths by poisoning, 1998 to 2005 (N = 1,553) 
* 	 Numbers and percentages in columns may differ from totals shown as individual cases may have more than one drug or substance 
involved in their death 
† 	 Other opiates includes unspecified opiates and analgesics containing an opiate compound 
‡ Alcohol is only recorded when it contributes to a polysubstance death 
§ Other prescription drugs includes non-benzodiazepine sedatives, anti-psychotics, cardiac and all other types of medication 
including over-the-counter medication 
** Other includes barbiturates, other amphetamines, hallucinogens, cannabis and other chemicals 
The annual number of deaths due to solvents varied slightly over the eight-year period. Most of these 
deaths occurred in young people: almost one-third (10) were aged between 11 and 14 years, and 42% 
(14) were aged between 15 and 19 years. 
The greatest increase in deaths by poisoning was outside Dublin, where the annual number has increased 
from 69 in 1998 to 119 in 2005 (Figure 3). In 2003, the number of cases reported outside Dublin 
surpassed the number reported in Dublin (city and county). The types of drug influencing the increase were 
benzodiazepines and other opiates and, to a lesser extent, heroin, methadone and cocaine. 
 12 HRB Trends Series 4 
Figure 3 Poisonings by place of residence, 1998 to 2005 (N = 1,529) 
To compare the increase in the number of poisonings over time and to account for changes in the 
population, an aggregated death rate per 100,000 population (aged 15–64 years) in the Regional Drugs 
Task Force (RDTF) areas was calculated for the years 1998 to 2001 and for the years 2002 to 2005 (Figure 
4). Overall, the national rate increased from 6.4 per 100,000 in the period 1998 to 2001 to 6.8 in the 
period 2002 to 2005. The rate increased between the two periods in all RDTF areas apart from the WRDTF, 
SWRDTF and NDRDTF. 
Figure 4 Rates of death by poisoning per 100,000 population (aged 15–64 years), by RDTF area,
aggregated for the years 1998 to 2001 and 2002 to 2005 (N = 1,397) 
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Indirectly drug-related deaths (non-poisonings) 
There were 889 non-poisoning deaths between 1998 and 2005 recorded by the NDRDI. The number of 

deaths due to non-poisoning increased steadily over the period, with small declines in 2000 and 2003 

(Table 5).
 
Table 5 Non-poisonings by year of death, 1998 to 2005 (N = 889) 
2005
 
Non-poisonings 168
 
1998 1999 2000 2001 2002 2003 2004 
64 84 79 101 126 112 155 
The majority of these cases were male (744, 83.7%) (Table 6). 
Table 6 Non-poisonings by gender, 1998 to 2005 (N = 889) 
2005
 
Male (n = 744) 146
 
Female (n = 145)
 22
 
1998 1999 2000 2001 2002 2003 2004 
53 69 64 86 90 92 144 
11 15 15 15 36 20 11 
Figure 5 shows that the majority of cases (602, 67.9%) were aged between 20 and 40 years. 
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Figure 5 Non-poisonings by age group, 1998 to 2005 (N = 887) 
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Overall, the median age of non-poisoning deaths was 31 years. The difference in median age between the 
genders fluctuated over the period (Table 7). 
Table 7 Non-poisonings by median age and gender, 1998 to 2005 (N = 887) 
1998 1999 2000 2001 2002 2003 2004 2005 
Median age in years 
All deaths 30 32 30 28 31 33 31 33 
Range* 18–49 18–47 18–50 17–52 20–50 20–54 19–48 19–52 
Male 28 31 32 30 30 34 31 32 
Female 33 35 23 25 33 31 30 35 
* Age range presented is the 5TH to 95TH percentile (90% of cases are included within this range). 
The number of non-poisonings in Dublin (city and county) increased steadily over the reporting period, 
more than doubling from 44 in 1998 to 107 in 2005 (Figure 6). Causes of death for non-poisoning cases 
are not presented in this paper but will be presented in a future publication. 
Figure 6 Non-poisonings by place of residence, 1998 to 2005 (N = 874) 
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To compare the increase in the number of non-poisonings over time and to account for changes in the 
population, an aggregated death rate per 100,000 population (aged 15–64 years) in the RDTF areas was 
calculated for the years 1998 to 2001 and for the years 2002 to 2005 (Figure 7). Overall, the national rate 
increased from 2.9 per 100,000 in the period 1998 to 2001 to 4.6 in the period 2002 to 2005. The rate 
increased between the two periods in all RDTF areas. 
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SERDTF SRDTF MWRDTF WRDTF NWRDTF NERDTF MRDTF ECRDTF SWRDTF NDRDTF State 
1998/2001 1.5 1.4 2.2 1.16 1.1 2.2 1.6 2.7 6.7 5.1 2.9 
2002/2005 2.2 2.5 3.2 1.24 1.5 3.2 1.8 3.5 9.8 10.5 4.6 
Regional drugs task force 
Figure 7 	 Rates of non-poisoning deaths per 100,000 population (aged 15–64 years), by RDTF area,
aggregated for the years 1998 to 2001 and 2002 to 2005 (N = 805) 
Conclusions 
This is the first report from the NDRDI and the first time that both directly and indirectly drug-related 
deaths have been calculated to provide a reliable estimate of the total burden of mortality related to drug 
use in Ireland. This will equip the State to respond in a timely manner, with accurate data, on drug-related 
deaths and deaths among drug users. These results can also help inform the next national drugs strategy, 
while the data can provide a baseline to monitor related actions. 
In order to improve the quality of the information in the NDRDI, it is important that the recommendations 
made in the review of the Coroner Service are implemented.10 This would assist with the standardisation of 
the information available from the coroners, including history of drug and alcohol treatment, imprisonment 
and prescribed medication. Another important recommendation is the more timely processing of toxicology 
samples. 
Heroin and other opiates, including methadone and opiate analgesia, continue to be mainly responsible for 
deaths by poisoning. 
The data from the NDRDI clearly show the impact of polysubstance use (of both illicit and licit drugs). 
National data show that polysubstance use is increasing among people who misuse drugs.15,16 However, 
deaths due to polysubstances are not a recent occurrence, and were seen consistently over the period 1998 
to 2005. 
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Overall, alcohol (in conjunction with one or more other drugs or substances) was implicated in a quarter of 
deaths by poisoning. This is an underestimation of the total number of such deaths because deaths due to 
alcohol poisoning alone are not included in this analysis. 
The number of deaths due to cocaine, alone or in conjunction with another drug, has risen continuously 
over the reporting period as its use has become more prevalent in the population.15, 17 
Prescription and over-the-counter medication is implicated in many poisoning deaths. Specifically, 
benzodiazepines, often in conjunction with an illicit substance, have been implicated in more deaths than 
any other drug. Currently, only small numbers of individuals are presenting for treatment for problem 
benzodiazepine use15 but the impact of this type of drug needs to be addressed within treatment and 
prevention services. 
The majority of cases of death by poisoning were males. This reflects international trends.5 
The majority of cases of death by poisoning were aged between 20 and 40 years, again reflecting 
international trends.5,18 Deaths due to solvents were the exception, with over 70% occurring in those aged 
19 years or under. Strategies need to be developed to address this specific risk among young people. 
A decrease in the number of deaths by poisoning was recorded in 2003. This trend was observed elsewhere 
in Europe. It may possibly be linked to the effect of the war in Afghanistan on the supply of opium to 
Europe during that period. A decrease in the number of prosecutions for drug possession in Ireland were 
also noted for that year.19 
Since 2003, the annual number of deaths by poisoning outside Dublin has surpassed the number reported 
in Dublin (city and country). This illustrates clearly that drug use is now a nationwide issue, compared with 
previous years when it was largely limited to the Dublin region. 
Calculating non-poisoning deaths allows, for the first time, the illustration of the total burden of mortality 
related to drug use in Ireland. This may be an underestimation of the true figures as history of drug use 
is not always available. The trend in non-poisonings shows a rise in almost every year of the reporting 
period. This reflects the increasing numbers in the population consuming drugs, taking risks and developing 
dependencies and other illnesses associated with drug use. The quality of the data recorded by the NDRDI 
will allow for further analysis of causes of death in non-poisonings. 
The number of deaths as a result of poisoning indicates that the most significant response required is a 
strategy to address overdoses, including actions to deal with overdose cases in a proactive manner at all 
levels including family, community, health services, gardaí and government. 
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